Mukesh Adhikari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mukesh Adhikari has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Rauf Anwar
Institut du Cerveau—Paris Brain Institute, 75013 Paris, France
1 shared publication - Bibhusan Shrestha
Department of Surgery, Kathmandu University Hospital, Dhulikhel 45200, Nepal
1 shared publication - Bishesh Khanal
NepAl Applied Mathematics and Informatics Institute for Research (NAAMII)
1 shared publication Donald Warne
Department of International Health, John Hopkins University, Baltimore, Maryland
1 shared publication- Dumitru Ciolac
Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
1 shared publication Emily M. Hawes
Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill
1 shared publication
Latest Publications
- 1 August 2025
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 185 (8) , 1040-1042
Comparing Indian Health Service Sites to Rural Physician Teaching Hospitals
This cross-sectional study compares characteristics of Indian Health Services hospitals and rural hospitals with Graduate Medical Education programs.
- 1 August 2025
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 185 (8) , 1040-1042
Comparing Indian Health Service Sites to Rural Physician Teaching Hospitals
This cross-sectional study compares characteristics of Indian Health Services hospitals and rural hospitals with Graduate Medical Education programs.
- Open Access
- 1 May 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (5) , 481
Assistive Artificial Intelligence in Epilepsy and Its Impact on Epilepsy Care in Low- and Middle-Income Countries
Epilepsy, one of the most common neurological diseases in the world, affects around 50 million people, with a notably disproportionate prevalence in individuals residing in low- and middle-income countries (LMICs). Alarmingly, over 80% of annual epilepsy-related fatalities occur within LMICs. The burden of the disease assessed using Disability Adjusted Life Years (DALYs) shows that epilepsy accounts for about 13 million DALYs per year, with LMICs bearing most of this burden due to the disproportionately high diagnostic and treatment gaps. Furthermore, LMICs also endure a significant financial burden, with the cost of epilepsy reaching up to 0.5% of the Gross National Product (GNP) in some cases. Difficulties in the appropriate diagnosis and treatment are complicated by the lack of trained medical specialists. Therefore, in these conditions, adopting artificial intelligence (AI)-based solutions may improve epilepsy care in LMICs. In this theoretical and critical review, we focus on epilepsy and its management in LMICs, as well as on the employment of AI technologies to aid epilepsy care in LMICs. We begin with a general introduction of epilepsy and present basic diagnostic and treatment approaches. We then explore the socioeconomic impact, treatment gaps, and efforts made to mitigate these issues. Taking this step further, we examine recent AI-related developments and their potential as assistive tools in clinical application in LMICs, along with proposals for future directions. We conclude by suggesting the need for scalable, low-cost AI solutions that align with the local infrastructure, policy and community engagement to improve epilepsy care in LMICs.
- 1 May 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (5) , 481
Open AccessAssistive Artificial Intelligence in Epilepsy and Its Impact on Epilepsy Care in Low- and Middle-Income Countries
Epilepsy, one of the most common neurological diseases in the world, affects around 50 million people, with a notably disproportionate prevalence in individuals residing in low- and middle-income countries (LMICs). Alarmingly, over 80% of annual epilepsy-related fatalities occur within LMICs. The burden of the disease assessed using Disability Adjusted Life Years (DALYs) shows that epilepsy accounts for about 13 million DALYs per year, with LMICs bearing most of this burden due to the disproportionately high diagnostic and treatment gaps. Furthermore, LMICs also endure a significant financial burden, with the cost of epilepsy reaching up to 0.5% of the Gross National Product (GNP) in some cases. Difficulties in the appropriate diagnosis and treatment are complicated by the lack of trained medical specialists. Therefore, in these conditions, adopting artificial intelligence (AI)-based solutions may improve epilepsy care in LMICs. In this theoretical and critical review, we focus on epilepsy and its management in LMICs, as well as on the employment of AI technologies to aid epilepsy care in LMICs. We begin with a general introduction of epilepsy and present basic diagnostic and treatment approaches. We then explore the socioeconomic impact, treatment gaps, and efforts made to mitigate these issues. Taking this step further, we examine recent AI-related developments and their potential as assistive tools in clinical application in LMICs, along with proposals for future directions. We conclude by suggesting the need for scalable, low-cost AI solutions that align with the local infrastructure, policy and community engagement to improve epilepsy care in LMICs.